Insider Trading Alert - VFC, ESRX, WLK, AFOP And MMS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Wednesday, Nov. 27, 2013, 160 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $788.24 to $484,583,953.98.

Highlighted Stocks Traded by Insiders:

VF Corporation (VFC) - FREE Research Report

Chugg Juliana L who is Director at VF Corporation bought 1,258 shares at $235.18 on Nov. 27, 2013. Following this transaction, the Director owned 1,258 shares meaning that the stake was reduced by 100% with the 1,258 share transaction.

The shares most recently traded at $235.97, up $0.79, or 0.33% since the insider transaction. Historical insider transactions for VF Corporation go as follows:

  • 4-Week # shares bought: 230
  • 4-Week # shares sold: 3,800
  • 12-Week # shares bought: 230
  • 12-Week # shares sold: 3,800
  • 24-Week # shares bought: 230
  • 24-Week # shares sold: 5,300

The average volume for VF Corporation has been 573,800 shares per day over the past 30 days. VF Corporation has a market cap of $25.9 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 55.61% year to date as of the close of trading on Wednesday.

V.F. Corporation designs and manufactures, or sources from independent contractors various apparel and footwear products primarily in the United States and Europe. The stock currently has a dividend yield of 1.79%. The company has a P/E ratio of 22.3. Currently there are 12 analysts that rate VF Corporation a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VFC - FREE

TheStreet Quant Ratings rates VF Corporation as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, reasonable valuation levels and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full VF Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Express Scripts (ESRX) - FREE Research Report

Ebling Keith J. who is EVP and General Counsel at Express Scripts sold 23,667 shares at $67.38 on Nov. 27, 2013. Following this transaction, the EVP and General Counsel owned 69,796 shares meaning that the stake was reduced by 25.32% with the 23,667 share transaction.

The shares most recently traded at $67.95, up $0.57, or 0.84% since the insider transaction. Historical insider transactions for Express Scripts go as follows:

  • 4-Week # shares sold: 77,409
  • 12-Week # shares sold: 77,409
  • 24-Week # shares sold: 87,137

The average volume for Express Scripts has been 5.2 million shares per day over the past 30 days. Express Scripts has a market cap of $54.4 billion and is part of the health care sector and health services industry. Shares are up 25% year to date as of the close of trading on Wednesday.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. The company has a P/E ratio of 29.2. Currently there are 13 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ESRX - FREE

TheStreet Quant Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Express Scripts Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Westlake Chemical Corporation (WLK) - FREE Research Report

Blakely Robert T who is Director at Westlake Chemical Corporation sold 2,534 shares at $112.21 on Nov. 27, 2013. Following this transaction, the Director owned 8,806 shares meaning that the stake was reduced by 22.35% with the 2,534 share transaction.

The shares most recently traded at $114.03, up $1.82, or 1.6% since the insider transaction. Historical insider transactions for Westlake Chemical Corporation go as follows:

  • 4-Week # shares sold: 2,534
  • 12-Week # shares sold: 2,534
  • 24-Week # shares sold: 8,464

The average volume for Westlake Chemical Corporation has been 369,300 shares per day over the past 30 days. Westlake Chemical Corporation has a market cap of $7.6 billion and is part of the basic materials sector and chemicals industry. Shares are up 43.43% year to date as of the close of trading on Wednesday.

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and fabricated building products. It operates in two segments, Olefins and Vinyls. The stock currently has a dividend yield of 0.79%. The company has a P/E ratio of 14.3. Currently there are 2 analysts that rate Westlake Chemical Corporation a buy, 2 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WLK - FREE

TheStreet Quant Ratings rates Westlake Chemical Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Westlake Chemical Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Alliance Fiber Optic Products (AFOP) - FREE Research Report

Ho Anita K who is Acting CFO at Alliance Fiber Optic Products sold 28,360 shares at $15.29 on Nov. 27, 2013. Following this transaction, the Acting CFO owned 22,954 shares meaning that the stake was reduced by 55.27% with the 28,360 share transaction.

The shares most recently traded at $15.15, down $0.14, or 0.9% since the insider transaction. Historical insider transactions for Alliance Fiber Optic Products go as follows:

  • 4-Week # shares sold: 33,360
  • 12-Week # shares sold: 571,860
  • 24-Week # shares sold: 782,860

The average volume for Alliance Fiber Optic Products has been 970,200 shares per day over the past 30 days. Alliance Fiber Optic Products has a market cap of $275.8 million and is part of the technology sector and electronics industry. Shares are up 150.25% year to date as of the close of trading on Wednesday.

Alliance Fiber Optic Products, Inc. designs, manufactures, and markets various fiber optic components and integrated modules for communications equipment manufacturers and service providers in North America, Europe, and Asia. The stock currently has a dividend yield of 1%. The company has a P/E ratio of 15.5. Currently there are no analysts that rate Alliance Fiber Optic Products a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AFOP - FREE

TheStreet Quant Ratings rates Alliance Fiber Optic Products as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Alliance Fiber Optic Products Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Maximus (MMS) - FREE Research Report

Andrekovich Mark who is Chief of Human Capital at Maximus sold 2,921 shares at $45.59 on Nov. 27, 2013. Following this transaction, the Chief of Human Capital owned 52,855 shares meaning that the stake was reduced by 5.24% with the 2,921 share transaction.

The shares most recently traded at $45.31, down $0.28, or 0.62% since the insider transaction. Historical insider transactions for Maximus go as follows:

  • 4-Week # shares sold: 2,921
  • 12-Week # shares sold: 42,516
  • 24-Week # shares sold: 43,516

The average volume for Maximus has been 406,700 shares per day over the past 30 days. Maximus has a market cap of $3.1 billion and is part of the services sector and diversified services industry. Shares are up 43.63% year to date as of the close of trading on Wednesday.

MAXIMUS, Inc. provides business process services to government health and human services agencies in the United States, Australia, Canada, the United Kingdom, and Saudi Arabia. The company operates in two segments, Health Services and Human Services. The stock currently has a dividend yield of 0.4%. The company has a P/E ratio of 27.0. Currently there are 5 analysts that rate Maximus a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MMS - FREE

TheStreet Quant Ratings rates Maximus as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Maximus Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Is FedEx Stock Salvageable? Probably, Just Not Yet

Is FedEx Stock Salvageable? Probably, Just Not Yet

The Electronic Platform That Took Markets Global

The Electronic Platform That Took Markets Global

Hershey Shares Get Boost From Bank of America's Double Upgrade

Hershey Shares Get Boost From Bank of America's Double Upgrade

Kass: The Lesson of Micron

Kass: The Lesson of Micron

Dow Rises Modestly as Wall Street's Got the Fed on Its Mind

Dow Rises Modestly as Wall Street's Got the Fed on Its Mind